Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R F van Vollenhoven
Efficacy and Safety of Subcutaneous Tabalumab, a Monoclonal Antibody to B-Cell Activating Factor, in Patients With Systemic Lupus Erythematosus: Results From ILLUMINATE-2, a 52-Week, Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
A 52-Week, Open-Label Study Evaluating the Safety and Efficacy of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, for Rheumatoid Arthritis
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
Journal of Inherited Metabolic Disease
Genetics
OP0253 a Phase Iii Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept or Placebo on Standard of Care in Patients With Active Class Iii or Iv Lupus Nephritis
A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Phase III, Randomised, Double-Blind, Multicentre Study to Evaluate the Efficacy and Safety of Vonoprazan Compared With Lansoprazole in Asian Patients With Erosive Oesophagitis
Gut
Gastroenterology
Efficacy and Safety of Teneligliptin Added Onto Canagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Study
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Double‐blind, Randomized, Placebo‐controlled, Phase II Trial of Baricitinib for Systemic Lupus Erythematosus: How to Optimize Lupus Trials to Examine Effects on Cutaneous Lupus Erythematosus
British Journal of Dermatology
Dermatology
Medicine
Anti-Il-7 Receptor Α Monoclonal Antibody (GSK2618960) in Healthy Subjects - A Randomised, Double-Blind Placebo-Controlled Study
British Journal of Clinical Pharmacology
Pharmacology